LV11426B - Shaving preparation - Google Patents
Shaving preparation Download PDFInfo
- Publication number
- LV11426B LV11426B LV950031A LV950031A LV11426B LV 11426 B LV11426 B LV 11426B LV 950031 A LV950031 A LV 950031A LV 950031 A LV950031 A LV 950031A LV 11426 B LV11426 B LV 11426B
- Authority
- LV
- Latvia
- Prior art keywords
- extracts
- hjih
- synthetic
- vav
- menthol
- Prior art date
Links
Landscapes
- Cosmetics (AREA)
Description
LV 11426
CPEflCTBO ΛΜ EPHTbM IIpe&JiaraeMoe Η3θβρβτβΗΗβ othochtch k MeanijHHe, b aacTHocTH, κ KocMeTmecKHM cpeacTBaM aaa 6pHTbH. H3BecTeH KpeM ara βρΗΤΜ (A. cb. CCCP N? 888998, MKH3 A61K 7/15, 3aHBJi. 12.08.80), b cocTaB κοτοροπ) βχολητ cTeapHH, Macno κοκοοοΒοβ, eaKoe Kaira, OKCHOTHJIHpOBaHHMH JiaypHJICyjIb4)aT HaTpHH, 6opHa» KHCJIOTa, OTayiIIKa, BOfla. H3 H3BecTHBix HaH6oJiee 6jih3khm no TexHHqecKOH cyuipocTH κ 3aBBJiaeMOMy «BJiaeTca KpeM ara βρπτΜ ( A. cb. CCCP N? 387715, MKH5 A61K7/15, aaaBJi. 25.11.71), coaepxaiiļHH CTeapHH KOCMeTHHecKHfi, cTeapHHOByio KHCJioiy, κηπηη raapoKCHa, Macjio KOKocoBoe, nranepHH, HaipHH juiopncTbra, pacTHTejibHbie SKCipaierbi, aHTHOKCHaaHT, οτχιγπικγ, Boay HHTbeByio. KpoMe τογο, oh coaepxHT cHJiHKaT Haipna h b KaaecTBe pacTHTeabHbre BKCTpaicroB - BoaHO-cnHpTo-DiHiiepHHOBbie SKcrpaKTbi TpHJincTHHKa βοληηογο h cnopbmia, a Taxxe xjiaaoHOBbiž SKCTpaKT KOHCKoro KanrraHa. Πρπ HCHQJib30BaHHH yKa3aHHoro KpeMa aira βρκτΒΗ o6ecneqHBaeTca Ηβκοτοροβ o6jienieHHe nponecca 6pHTb«, a Tajcace npoTHBOBocnajiHTejibHoe h 6aicrepHHHaHoe aeficTBHH. IīpeanaraeMoe cpeacTBO ara 6paTba, coaepxamee CTeapHH KocMeTHHecKHŽ h/hjih CTeapHHOByK> khcjioty, κ&πεχ raapoKcaa, Macao KOKocoBoe, mHaepHH, Haipad xjiopHCTbiH, pacTHTeabHbie SKCTpaierbi, aHTHOKCHaairr, OTayuiKy, Boay nHTbeBjrao , aonojiHHTejibHo coaepxHT aHHOHaKTHBHoe CHHTeTHaecKoe noBepKHocTHo-aKTHBHoe BemtecTBO (ΠΑΒ), MeHTOJi h cHHTeTHHecKHH noanMep, a b KaaecTBe pacTHTeabHbix SKCTpaicroB - SKCTpaicrbi μητμ hjīh xeHbiiieira, κορπΗ coaoaKH hjih TbicaaejiHCTHHKa, poanonbi, aeB3ea hjih 3aeyrepOKOKKa, npn cjieayiomeM cooTHOiiieHHH KOMnoHeBTOB, Mac%: CTeapHH KocMeTHHecKHH h/hjih creapHHOBaa KHcaoTa 24,0-28,0 Macjio KOKocoBoe 6,0 -10,0 2 2 6,0 -10,0 7,0 -8,5 0,5 -1,5 5,0 -10,0 0,05 -0,2 0,05 -0,5 0,4 -1,8 0,05-0,5 0,8 -1,5 ocTajībHoe maaepBH KaJIHH ΙΉΛρΟΚΟΗΛ HaTpHH ΧΛΟρΗΛ aHHOHaKTHBHoe cHHTeraHecKoe ΠΑΒ ΜβΗΤΟΛ pacTHTejibHbie SKCTpaKTbi cHHTeTmecKHH nojiBMep
aHTHOKCHaaHT oTitymKa
Bo^a 3KCTpaKTbi pacTBTejibHoro cbipba BBejieHM b cocrraB b βηλθ BOHHo-cnaproBbrc, BOflHO-CnHpTO-mHUepHHOBbIX 3KCTp3KTOB, HJIH B ΒΗΛβ ΚΟΗϋβΗΤρβΤΟΒ. npejUiaraeMblH COCTaB HBJIJieTCJI ΒΜΟΟΚΟθφφβΚΤΒΒΗΒΙΜ CpeflCTBOM sra 6pHTbH, 6jiaronapJi ero ipoaHOMy nonoxHTejibHOMy neacTBHK>: cpejicTBO χοροαιο pa3MarqaeT bojioc, co3aaeT Ha κοχβ ycTOHRHByio neHy Ha iipojiojDKHTejībhoe BpeMa, o6ecneHHBaeT xopomee CKOJiLxeHae Jie3BHH 6pHTBbL KpoMe τοιό, ycTpaH«eT h npeaynpexnaeT pa3jpaxeHae a BocnarieHBe κοχβ, cnoco6cTByeT 3aXHBJieHaJO ΜβΗΚΗΧ Π0ρβ30Β a paHOK. npeaJiaraeMoe cpejicTBO coaeTaeT b ce6e KaaeerBa HaTypajibHoro Mbuia, χοροιπο pa3MHrqaiomero bojioc, a caHTeTaaecKoro Mbina, co3jiaiomero xopomyro neHy. lipa 3TOM OTcyrcTByeT pa3jrpaxaiomee a nepecymHBaiomee fleacTBae. Πο CpaBHCHBIO C B3BeCTHbIMB CpejļCTBaMH B 3aHBJIHeMOM COCTaBe CymeCTBeHHO cHaxeH npoaeHT BBeaeHBH CTeapaHa b/bjib CTeapaHOBoa Kacjioībi ( b npoTOTane - 31-33%6 b 3aaBJiaeMOM - 24-28%). TaKoa nojioxaTejibHbia Βφφβκτ o6ecneaaBaeTca 3a caeT BBeaeHB» cneaaajībHo nojio6paHHoro KOMmieKca KocMeTaaecKoro cbipba: CTeapaHa b/hjib CTeapaHOBoa khcjiotm, kokocoboto Macaa, Kajiaa ranpoKca^a, caHTeTaaecKoro ΠΑΒ a caHTeTaaecKoro nojiaMepa b ηοββεχ 3aaBJiaeMbix cooTHoineHaax.
XapaKTepacraKa ββολβμβιχ κομποaeHTOB.
Una coajiaHaa Ha κοχβ o6hjilhoh a υοτοηηηβοη neHbi, a Taoce npaaaHaa Macce cpejicTBa iuiacTBHHocTB a coKpamenaa τβχΗΟΗΟΓΒΗβοκοΓΟ npoaecca (ycKopeHaa i LV 11426 nponecca KpHCTajurasanHH Maccbi) b cocTae cpeflCTBa BBeaeHH b cnenHajībHO nofloSpaHHOM cooTHoineHHH cjieayiomHe κομποηθητη: CTeapHH h/hjih CTeapHHOBa» KHCJioTa, KOKocoBoe Macjio, Kanna rajupoKcnj, aHHOHaKTHBHoe CHHTeTircecKoe ΠΑΒ, cHHTeTHnecKHH nojiHMep. CTeapHH, HanpHMep, MapKH Α,Β, TN 10-04-02-83 91, hjih MapKH Tefacid, npeflCTaBJUiiomHe co6oh cMecb cTeapHHOBOH η najībMHTHHOBOH khcjiot, hjih CTeapHHOBaa KHCJioTa, GOST 6484-64, BBeneHbi b cocTaB b KOJinnecTBe 24,0 -28,0%. IlpeflCTaBJiSHDT co6oh HeiuyfiKH 6ejioro hjih cBeiJio-KpeMOBoro nseTa.
KoKoeoBoe Macjio h cTeapHHOBaji KHCJioTa cocTaBJiHBor XHpOByK> ocHOBy cpeacTBa. KoKocoeoe Macjio npeHCTaBJiaeT co6oh TBepflbiž pacTHTejibHbifl xnp, COflepXaHļHŽ mHnepHHbl JKHpHbK KHCJIOT. ΒββΛβΗΟ B COCTaB B KOJĪHHeCTBe 6,0 -10,0%. BeeneHHe cTeapHHa hjih cTeapHHOBOH khcjioth MeHee24,0% h KOKocoBoro Macjia MeHee 6,0% He o6ecneHHBaeT aaBepmeHHH npoiiecca oMbineHHfl h co3jiaHna ο6ηιιβηοη neHbi, a BBeaeHHe Bbime BepxHero npenejia-CTeapHHa hjih cTeapHHOBOH khcjioth 6ojiee 28,0% h kokocoboio Macjia 6ojiee 10,0% - cHHxaeT noTpe6HTejibCKHe KanecTBa cpeacTBa - cpencTBo CTaHOBHTca HSJIHUIHe ryCTbIM H XeCTKHM H3-3a HaJIHHHH HeOMbUieHfftK ΧΗρΟΒ, ΤΓΟ ΠρΗΒΟΛΗΤ K npOropKaHHIO MbDIOB.
KajiHH rHHpoKCHH, GOST 24363-80, BBeneH b cocTaB b KOJinnecTBe 7,0-8,5%, b nepecaeTe Ha 100%, jsm oMbuieHHH χηροβοη ocHOBbL Bee/ieHHe MeHee 7,0% He o6ecneqHBaeT 3aBepuieHHH npoaecca oMbuieHHH, 6ojiee 8,5% - noBbniiaeT uiejioiHocTb cpencTBa.
AHHOHaKTHBHOe HOBepXHOCTHO-aKTHBHOe BemeCTBO, HanpHMep, HaTpHH HJIH MarHHH JIaypHJICyJIbφaT OKCHSTHJIHpOBaHHblH, HJIH MaiHHH jiaypHjrcynrb<ļK>cyKHHHaT, BBeneHbf b cocTaB b KOJiHnecTBe 5,0-10,0% jum cosnaHHJi ο6ηιιβηοη neHbL ΒββΛβΗΗβ MeHee 5,0% He o6ecnenHBaeT xopomero neHoo6pa30BaHHH, 6ojiee 10,0% - CHHxaeT CTa6HJibHocTb CTpyicrypbi cpencTBa. CHHTeTHaecKHH nojiHMep, HanpHMep, conojiHMep nojiH3THJia h nojiHCHJioKcaHa HJIH ΛΗΜβΤΗΚΟΗ KOHOJIHOJI, ΒΒβΛβΗ B COCTaB B KOJIHHeCTBe 0,4-1,8% ĶH5I CTa6HJiH3anHH neebi h o6ecneneHHa CKOJibxeHHH βρκτΒΜ npn conpHKocHOBeHHH c KOxen. BeejieHHe c hhtcthaeckoro nojmMepa 6ojiee hjih MeHee 3aaBJweMbix npejiejiOB He o6ecnennBaeT θφφεκτΗΒΐιοπ) aeHCTBHa. 4
DienepHH, GOST 6824-76, BBejieH b cocrae b KaaecTBe CMHnaiomeH AoOaBKH b KOJiHHecTBe 6,0 - 10,0%. BBeaeHae maiiepHHa HHxe yKa3aHHbix npeaenoB He o6ecneHHBaeT θφφβκτπΒΗΟΓο cManaioiiiero neHCTBHsi, a 6ojiee - HapymaeT CTpyKTypy cpeflCTBa.
HaTpaa juiopaa, GOST13830-91, BBeaeH b cocTae b KaaecTBe peryjijrropa BH3KOCTH MbUIbHOH MaCCbl B HpOHeCCe OMbUieHHH, a Taoce ΛΠΗ npOHBJieHHfl nepJiaMyrpoBoro δφφβκτβ Maccbi b KOJiHHecTBe 0,5-1,5%. Bee^eHHe MeHee 0,5% hjih 6oJiee 1,5% - HapymaeT CTpyKrypy cpejicTBa. 3KcrpaKTbi pacTHTejibHoro cbipbH, a HMeHHO, SKCTpaKTbi μ$γγβι hjih xeHbineH5i, Kopu» cojioakh hjih TbicjpiejiHCTHHKa, po^HOJibi, jieB3eji hjih ajieyrepoKOKKa, BBejieHbi b cocTae b KOJinnecTBe 0,05 - 0,5% hjih οκ333ηηη 6jiaronpHjrraoiT> HHTaiomero h TOHH3Hpyiomero ΑββοτΒΗΗ Ha Koxy. 06ecneHHBa»T TaKxe aHTH6aKrepHajibHoe, npoTHBOBOcnajiHTejibHoe a^hctbhh. IIpeAynpexAaioT h ycTpaHHH)T pa3ApaxeHHe, BocnajieHHe κόχη nocjie 6pHTbH, cnoco6cTByroT 3axHBJieHHK> MejiKHK nope30B h paHOK 6jiarojiapH HajiHHHio b cocTaee ββγπιμηηοβ rpynnbi B, C, a TaKxe πιηκο3ηαοβ, Ay6HJibHbix BemecTB, xnpHbix opraHHHecKHK KHCJIOT. 3KCTpaKTbi pacTHTejibHoro cbipbH Moryr 6brrb BBejieHbi b βηαο βοληο-οπηρτοβμχ, ΒΟΑΗΟ-ΟΠΗρΤΟ-ΠΙΗΗβρΗΗΟΒΜΧ SKCTpaKTOB HJIH KOHDteHTpaTOB. ΒΒβΑβΗΗβ BKCTpaKTOB MeHee 0,05% hjih 6ojiee 0,5% He o6ecneqHBaeT onTHMajībHoro eHOJIOrHHeCKH ΗΚΤΠΒΗΟΓΟ ΑβΗΟΤΒΗΗ.
MeHTOJI ΒΒβΛβΗ B COCTaB CpeflCTBa B KOJIHHeCTBe 0,05-0,2% AID! C03AaHHH ycnoKaHBaiomero h ocBeacaiomero Βφφβκτβ. BBeneHne MeHTOJia MeHee hjih 6ojiee 3aHBJiHeMbix cooTHomeHHH He o6ecneHHBaeT onTHMajībHoro achctbhh. B KaaecTBe aHTHOKCHAaHTa juvi npeAOTBpameHH» προropKanna χκροΒ h CTa6HJIH3aHHH MbUIbHOH OCHOBbl B ΚΟΜΠ03ΗΗΗΚ) B KOJIHHeCTBe 0,05 - 0,5% BBeAeH hohoji. BeeAeHHe ηητηοκοηαηητβ HHxe 3aHBJiaeMoro 3HaqeHHH ne o6ecneHHBaeT CTa6HJIbHOCTH Η ΙφΗΒΟΑΗΤ K nporOpKaHHIO ΧΗρΟΒΟΗ OCHOBbl,
Bbnne 3aaBJiHeMbix npeaejioB - Μοχβτ Bbi3bmaTb ajuiepraqecKyio peaKHHio. JJjīH HpHZiaHHH CpeflCTBy ΠρΗίΓΤΗΟΓΟ φ3ΗΤ33ΗΗΗΟΓΟ 3anaxa B COCTaB BBeAeHa OTAyiHKa b KOJinnecTBe 0,8-1,5%. 5 LV 11426 npejuiaraeMoe co*iexaHHe κομποη6ητοβ HMeHHO b 3aHBJiHeMbix cooTHOiueHHax o6ecneqHBaK)T xopomyK> ycxoHHBByio neHy, pa3MHrqaex bojioc b co3flaeT DiaAKyio CKOJib3aiuyK> noBepxHoerb, ηχο o6jienaeT 6paxbe h cHExaex BepoarrHOCTb noHBJieHHH nope30B, a xaKxe pa3ApaxeāaH a BocnajieHaa κόχη.
CpeacTBo ajih 6pnxba aparoTaBjmBanr cjieayK>iiļBM o6pa30M. ΠρΒΜβρ 1.
Peaemypa npaBeaeHa H3 pacaera nparoTOBJieHaa 1000 κγ γοτοβοιό npoayKTa. cTeapBH KocMeTaaecKaS 240,0
Macjro KOKoeoBoe 80,0 maaepHH 70,0
KajīBH rajtpoKCHA 80,0 CBHTeTBMecKaa nonBMep 7,0
HaTpaa xjiopaa 11,0 CBHTeTHHecKoe ΠΑΒ 70,0
MeHTOJi 1,0 BKCipaKTbi ΒθΛΗο-cnapTo-maBtepaHOBbie KOpHSf COJIOflKH, MHTbl B ΧβΗΜΙΙβΗΗ 2,0 aHTBOKCBaaHT 1,2 OT<nyiiiKa 10,0 bom 427,8 īlpejlBapBTeJIbHO B OXflejIbHbIX βΜΚΟΟΤΗΧ ΓΟΤΟΒ5ΓΓ paCTBOpbl 11,0 ΚΓ ΗΒΤρΗΒ xjiopB.ua b 55,0 κγ BOAbi, h pacTBop MeBrrojia - 1κ r b oxAyniKe ΙΟ,Οκτ. TeMnepaTypa boam 50-60°C. flajiee b 3MaJiHpoBaHHbiS peaierop 3aipyxaK>T 240,Οκγ CTeapHHa, 1 ,2kt aHTBokcBjiaHTa b 80,Οκγ kokocobofo Macjia. Maccy rmaBjrr npa TeMnepaType 85-90°C npa boctobhhom nepeMeiiiHBaHBE. B peaKrop xana "Frima"3arpyxaiox ocTaBineeca ot nparoTOBJieHHH pacTBopa peaeinypHoe KOjmaecTBo βολή, HarpeToft ao 50-60°C, KajīBB rHApOKCHA 80,Οκγ h niEiiepHH 70,Οκγ. CMecb HarpeBaioT ao 60-65°C. flanee bboajtt pacnuiaBJieHHbie χπροΒΜβ κομποηθητμ ma npoB6A6HBB npoaecca OMbuieHBH. PeaKjļBK) npoBOAsrr npa xeMnepaType 85-90°C boa BaKyyMOMB xeaeHBe npBMepHO 30-60 mhhjt. flajiee MeaneHHO bboastt pacxB0p Harpna xjiopHAa. PeaKUHK) OMbmeHHB προΒΟΑΒΤ eīpe b TeieHae 15-20 6 mhhjt. ΓΤρΗ oxjiaxjieHHH ao 60-65°C b peaicrop bbo^ht caHTeTanecKoe ΠΑΒ (70,0κγ) B CHHTeTHHeCKHH nOJIHMep (7,0kt). npH flaJItHeHUieM ΠΟΗΚΧβΗΗΗ TeMnepaTypw λο 45-50°C ββολητ pacTHTejibHbie BKCTpaKThi ( 2,0κγ) b pacTBop MeHTOJia b oTayniKe.
Maccy BbicTaaBaioT b TeaeHae 24 aacoe a nepeaaroT Ha προΒβρκγ cooTBeTCTBaa noKa3aTejiHM TN 64-19-35-90 " KpeMbi jum 6paTba". lipa nojioacHTejibHOM pe3yjibTaTe aHarra3a Maccy <f>acyiOT. OH3HKo-xBMaaecKae noKa3aTejia nparoTOBJieHHoro cpeacTBa cjieajromae: BHeuiHHB bba - o^HopoaHaji KpeMOo6pa3Haa Macca ΐϊΒβτ - 6ejibia 3anax - 3ejieHbia, CBexaa MaccoBaa aojia 3capHbix khcjiot,% - 31,6 KacjioTHoe aacjio -2 aeHHoe qacjio,CM^ - 560 yCTOHBHBOCTb ΠβΗΜ,% - 95
BoaopoaHbla noKa3aTejib pH 10% βοληογο pacTBopa- 10,6 coaepxaHae οβο6οληοη mejioaa - Ηβτ, bto cooTBeTCTByeT ipe6oBaHHHM TN κ jjaaHbiM noKa3aTejiHM. IIpHMep 2.
Peaemypa npHBeaeHa a3 pacaeTa aparoTOBJieHaa ΙΟΟΟκγ γοτοβογο npojyKra. Cnoco6 npniOTOBJieHHĀ aHajionneH onacaHHOMy b IIpHMepe 1. cTeapaH KocMeTaaecKHH 250,0
Macjio KOKOCOBoe 100,0 maiiepHH 60,0
Kanna ΓΗ^ροχΛορΒΛ 80,0
Haipaa xjiopan 15,0 cHHTeTaaecKoe ΠΑΒ 50,0
MeHTOJi 2,0 BKCTpaKTbi BonHo-cnapTOBbie κορΗίϊ co/ιολκη, jieB3ea a poaaojibi po30Boa 0,5 CHHTeTHaecKaS nojiaMep 13,0 aaTHOKcaaaHT 0,5 0T^yniKa 15,0
Boaa 414,0 7 LV 11426 OH3HKo-xHMHsecKHe noKa3aTejiH npHroTOBJieHHoro cpeacTBa cjieajrromae: BHeiHHHH ΒΗΛ - OflHOpOflHaH KpeMoo6pa3Ha$i Macca ιΐΒβτ - cjienca KpeMOBbrii 3anax - 3eJieHMH, CBescaž MaccoBaa bojih XHpHbix khcjiot,% - 35,0 KHCJIOTHOe hhcjio -2,3 neHHoe qHCJio,CM^ - 520 ycTOHTOBocTi neHW,% - 92 BOKopoAHbra noKa3aTenb pH 10% βοληογο pacTBopa- 10,7 coaepxaHHe cbo6oaho& mejioaH - Ηβτ, ΤΓο οοοτΒβτοτΒγβτ TpeSoBaHHJiM κ TN κ noica3aTčjraM . ΠρΗΜβρ 3.
Peuemypa npHBeaeHa H3 pacaeTa nparoTOBJieHH» 1000 κγ γοτοβογο προΛγκτβ.
Cnoeo6 ΠρΗΓΟΤΟΒΠβΗΗΗ ΒΗβΛΟΠΡΙβΗ OOHCaHHOMy B IIpHMepe 1. CTeapHH KocMeTHiecKHH 280,0
Macjio κοκοοοΒοε 60,0 umneņzH 100,0
KaJIHH ΙΉ,ΠρΟΧΛΟρΗΛ 85,0
HaTpHH ΧΛΟρΗΛ 5,0 cHHTeTHaecKHH ΠΑΒ 100,0
MeHTOJi 0,5 SKCTpaKTH BoaHO-cnHpTOBbie TbicaraejiHCTHHKa, anejrrepoKOKKa, JieB3ea 5,0 cHHTeTHaecKHH nojiHMep 6,0 aHTHOKCHflaHT 5,0 oT^vniKa 8,0
Boaa 345,5 ΦΒβΗΚΟ-ΧΗΜΗΗεοκΗβ noKa3aTeJiH npHroTOBJieHHoro cpe^cTBa cjiefljnomae: BHeinHHH BHjļ - oflHopoaHaa KpeMoo6pa3Haa Macca ΒίΒβτ - 6ejibiž 3anax - 3ejieHbiž, CBeacaH MaccoBaa λοπη xcnpHbix khcjiot,% - 34 KHCJIOTHOe tocjio -4,3 8 neHHoe hhcjio,cm3 - 600 yCTOHHHBOCTb ΠβΗΒΙ,% - 93 ΒΟΛοροΛΗΒώ noKa3aTejib pH 10% βοληογο pacTBopa- 10,9 co^epacaHHe cbo6o,hhoh mejio*ra - Ηβτ.
ΠρΗΓΟΤΟΒΠβΗΗΟβ Cpe^CTBO JUN 6pHTBH ΠΟ HpHMepaM 1-3 yj[OBJieTBOpj[eT
Tpe6oBaHHHM Me2iflyHapoflHoro crraHaapTa ISO, cepHH 9000 hmchho b 3aaBJiaeMBIX COOTHOUieHH5IX ΚΟΜΠΟΗβΗΤΟΒ. IIpeftrtaraeMoe cpeacTBo HaHocar Ha BJiaxHyK> khctohkjt ma 6pHTBx, 3aTeM pacnpeaeJiHioT Ha Koace ao nojiyqeHHH neHBi.
CpeacTBO χοροιπο pa3MarqaeT bojtoc, co3aaeT o6HJiBeyio h ycTOH«mByio neHy, o6ecneHHBaeT Jiencoe cKOjn>xeHHe jie3BHH βρπτΒΒΐ no κοχβ. OKa3Bmaer HHTaromeee h TOHH3Hpyiomee aežcTBHe, npeaynpexaaeT noKpacHeHHe, pa3apaxeHHe h BoenaaeHHe κόχη, a TaKxe cnoco6cTByeT 3ηχηβπ6ηηκ> M6JIKHX HOpe30B H paH. 9 LV 11426
ΦΟΡΜΥΛΑ H30BPETEHHH 1. CpeacTBO jum βρπτΜ, conepxamee CTeapHH KocMeTHHecKHH h/hjie cTeapHHOBjTO KHCJioiy, KajiHH raapoKCHfl, Macjio KOKocoBoe, nracepnH, Haipan xjiopHfl, pacTHTejibHtie SKCTpaKTbi, aHTHOKCHflaHT, OTayinKy, Boay nHTbeByio , ο τ jiHHaiomeeca τβΜ, hto oho flonojiHHTejibHo co,aepxHT βηηοηβκγηβηο6 cHHTeTHHecKoe noBepxHocTHO-aKTHBHoe BemecTBo (ΠΑΒ), ΜβΗτοπ h CHHTeTHHeCKHŽ nOJIHMep, a B Ka'ieCTBe paCTHTeJIbHbK SKCTpaKTOB - SKCTpaKTLI Μ5ΓΓΜ HJIH ΧβΗΜΠβΗΗ, KOpHM COJIOflKH HJTH TLICJTļeJIHCTHHKa, pOtfHOJIbl, JI6B36B HJĪH 3jieyrepoKOKKa, npH cjieayK)ineM coothoiiichhh κοΜποπβΗΤΟΒ, Mac%: CTeapHH KocMeTHHecKHfi h/hjih CTeapHHOBaa KHCJioTa 24,0-28,0
Macjro KOKocoBoe 6,0 -10,0 ranHepHH 6,0 -10,0
KanHH rajtpoKCHfl 7,0 - 8,5
Haipna xjiopHfl 0,5 - 1,5 aHHOHaKTHBHoe cHHTeTHnecKoe ΠΑΒ 5,0 -10,0
MeHTOJi 0,05 -0,2 pacTHTejibHbie SKCTpaKru 0,05 -0,5 cHHTeTHHecKHS nojiHMep 0,4 -1,8 aHTHOKCHaaHT 0,05-0,5 oTHyuiKa 0,8 -1,5
Boaa ocTajīBHoe 2. CpeacTBO χπχ 6pHTbH no n.l, OTJiHiaiomeecii τβΜ, hto SKCTpaKTbi paCTHTeJIbHOFO Cbiphfl BBeneHbl B Baae BOHHO-CnHpTOBbDt, BOflHO-CHHpTO-DĪHHepHHOBbDL SKCTpajfCTOB HJIH B BHJie KOHIieHTpaTOB. LV 11426 10 ΡΕΦΕΡΑΤ CPEflCTBO JUia ΕΡΗΤΒΜ
Η3θ6ρβΤβΗΗβ OTHOCHTCH K MejIHIIHHS, B «laCTHOCTH, K KOCMeTHHeCKHM
CpeACTB flJIH 6pHTbH. ĪIpeflnaraeMoe peacTBO «jm 6pHTta xopomo pa3MHrcaeT bojioc, coaaaeT Ha κοχβ ycTod^HByx> neny Ha nponojocHTeJibHoe BpeMH, o6ecneHHBaeT xopomee cKOJiKxeHHe jie3Baa 6pHTBbi. KpoMe τογο, ycTpasseT h npeayiipexnaeT pa3jipaxeHHe h BocnajieHHe κόχη, cnoco6cTByeT 3axHBJieHHK> mčjīkhx nope30B h paHOK. B cocTase cpeflCTBa cTeapHH KocMeTHHecKHH hjih creapHHOBa» KHCJioTa, KOKOCOBOe MaCJIO, KaJIHH ΓΗϋρΟΚΟΗΛ, HaTpHH φπΟρΗΛ, SKCTpaKTbl paCTHTeJIbHOIO cbipbH, a Tarace βητηοκοηαηητ, OTjiymKa, Bo.ua.
CpeflCTBO OTJIHHaeTCH ΤβΜ, HTO JIOIIOJIHHTeJILHO BBeaeHbl ΒΗΗΟΗβΚΤΗΒΗΟΟ cHHTeTHnecKoe ĪIAB, CHHTeTBraecKHH nojiHMep h mchtoji , h HaftueHO Hoeoe COOTHOUieHHe ΒΒ6Α6ΗΠΧ H3B6CTHbIX ΚΟΜΠΟΗβΗΤΟΒ ΚοΜΠΟΗβΗΤΜ Β3ΗΤΜ B OnpefleJieHHbDC COOTHOIII6HHHX. 3KCTpaKTbI paCTHTeJIBHOro cbipbH BeeaeHbi b Baae βοηηο-οπηρτοββιχ hjih βολβο- cnHpTo-mHiiepHHOBbix SKCTpaKTOB HJIH KOHHeHTpaTOB.
Claims (1)
- LV 11426 IZGUDROJUMA FORMULA 1.Skūšanās līdzeklis, kurš satur stearīnu vai stearīnskābi, kālija hidroksīdu,, kokosa eļļu, glicerīnu, nātrija hlorīdu, augu izejvielu ekstraktus, antioksidantu, aromātisko piedevu, dzeramo ūdeni, atšķiras arto, ka tas papildus satur anionaktīvo sintētisko virsmas aktīvo vielu (VAV), sintētisko polimēru un mentolu, pie kam kā augu izejvielu ekstraktus ievada piparmētras vai žeņšeņa, lakricas sakņu vai pelašķu, radiolas, levzejas vai eleuterokoka ekstraktus sekojošās komponentu masu attiecībās, %: stearīns vai stearīnskābe 24,0 -28,0 kokosa eļļa 6,0 - 10,0 glicerīns 6,0 -10,0 kālija hidroksīds 7,0 - 8,5 nātrija hlorīds 0,5 -1,5 anionaktivā sintētiskā VAV 5,0 -10,0 mentols 0,05 - 0,2 augu izejvielu ekstrakti 0,05-0,5 sintētiskais polimērs 0,4 - 1,8 antioksidants 0,05 -0,5 aromātiskā piedeva 0,8 -1,5 dzeramais ūdens pārējais 2. 1.punktā aprakstītais skūšanās līdzeklis, atšķiras ar to, ka augu izejvielu ekstrakti tiek lietoti ūdens-spirta, ūdens-spirta-glicerina ekstraktu vai koncentrātu veidā.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LV950031A LV11426B (en) | 1995-02-14 | 1995-02-14 | Shaving preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LV950031A LV11426B (en) | 1995-02-14 | 1995-02-14 | Shaving preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
LV11426A LV11426A (lv) | 1996-08-20 |
LV11426B true LV11426B (en) | 1996-12-20 |
Family
ID=19735880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LV950031A LV11426B (en) | 1995-02-14 | 1995-02-14 | Shaving preparation |
Country Status (1)
Country | Link |
---|---|
LV (1) | LV11426B (lv) |
-
1995
- 1995-02-14 LV LV950031A patent/LV11426B/lv unknown
Also Published As
Publication number | Publication date |
---|---|
LV11426A (lv) | 1996-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005319184C1 (en) | Oral care compositions containing free-B-ring flavonoids and flavans | |
RU2270668C2 (ru) | Оральная антигингивитная композиция | |
EP0579383B1 (en) | Antibacterial antiplaque mouthwash composition | |
JP2752138B2 (ja) | 石けん組成物 | |
KR102467709B1 (ko) | 리포솜 조성물 | |
AU2011359406A1 (en) | Taste -masked oral care compositions | |
EP3223780A1 (en) | Oral care products and methods of use and manufacture thereof | |
WO2011055707A1 (ja) | 歯磨剤組成物 | |
EP0284765A2 (en) | Soap based gel sticks | |
CA2461462A1 (fr) | Composition cosmetique pour le soin de la peau et des cheveux de l'homme | |
JP2000063262A (ja) | 抗菌性化粧料組成物 | |
LV11426B (en) | Shaving preparation | |
JP4294628B2 (ja) | 泡沫洗浄剤用組成物及び泡沫洗浄剤 | |
GB2195888A (en) | A dentifrice containing a poly(hydroxypropyl ether)nonionic surfactant and a specified protein-derived salt | |
CN109350556A (zh) | 一种防龋齿牙膏及其制备方法 | |
JP2011098915A (ja) | 歯磨組成物 | |
KR20200064622A (ko) | 박하, 오레가노, 생강 및 계피의 복합추출물을 함유하는 탈취 및 항균용 화장료 조성물 | |
CN110628537A (zh) | 一种抗菌除螨香皂 | |
RU2646484C2 (ru) | Отбеливающие композиции для ухода за полостью рта, содержащие жирные амфифилы | |
CA2822027C (en) | Halogenated biphenols as antibacterial agents | |
CN113993594A (zh) | 牙齿用贴片 | |
JP3626449B2 (ja) | 洗浄用シート | |
KR100672247B1 (ko) | 면도보조제 조성물 | |
KR20200093521A (ko) | 치마제 조성물 | |
KR102106243B1 (ko) | 쉐이빙 부스터 화장료 조성물 |